• NGLY1 in The New Yorker!

    Open science and social media were key in the discovery and growth of the NGLY1 rare disease community. Article by Seth Mnookin.

  • NGLY1 Deficiency Research

    In June 2012, the Freeze Lab pioneered research into the clinical treatment of the rare disorder, N-glycanase deficiency.

  • NGLY1 Families Connect

    On February 28, 2014, researchers and 5 NGLY1 families from across the world met for the first ever symposium on N-glycanase deficiency.

Showing posts with label NORD. Show all posts
Showing posts with label NORD. Show all posts

Saturday, January 24, 2015

2015 Running for Rare Diseases

A diagnosis is the first step toward a cure.  Bertrand, Victoria and Winston Might are proud to partner with Pam Lynch from Genzyme on the 2015 Running for Rare Diseases Team to support the Undiagnosed Diseases Network.
NGLY1.org is proud to partner with the 2015 Running for Rare Diseases Team to raise awareness and funds in support of the Undiagnosed Diseases Program at NIH through NORD.  

It wasn't that long ago that all of our NGLY1 kids were undiagnosed and without hope.  A diagnosis can change so much!  

Duke, Stanford, Baylor, Harvard, NIH are among the nodes in the Undiagnosed Diseases Program that have played/continue to play an active role in NGLY1 research.  

It is our hope that through our encouragement and support, these fantastic scientists will be able to help many more undiagnosed kids as well.

Facts about this year's team:
  • 102 Running Team Members (23 - Boston Marathon, 2- Paris Marathon, 80- Providence Half and Full Marathon – a few are doing more than one race)
  • 74 Runner/Patient partnerships
  • 58 Rare Disease Communities represented  (See Table below)
  • Runners from 14 different states and 3 different countries
  • Patient Partners from 19 different states and 3 different countries

Rare Disease Communities Represented
Gaucher